TELL will be participating in Pensar en Grande’s support program for entrepreneurs
TELL has been one of the startups selected to participate in a silver economy innovation program offered by Pensar en Grande.
We won two Alzheimer’s Association’s Publication of the Year Awards!
We are thrilled to have obtained two Alzheimer’s Association’s Publication of the Year Awards, in the categories «Diversity and Disparities» and «Artificial Intelligence for Precision Dementia Medicine». Congratulations to both teams!
TELL to join the Alzheimer’s Moonshot Community
Our app TELL was selected to join StartUp +Health’s Alzheimer’s Moonshot Community, supported by Gates Ventures and the Alzheimer’s Drug Discovery Foundation. Turning neurolinguistics into a tool for dementia assessments. For more information, click here.
New grant from the Swiss National Science Foundation
This project, entitled «LiMoN-2: Linguistic Markers of Neurodegeneration in Bilinguals», will allow us to identify syndrome-specific speech and language markers that may signal neurodegenerative processes in multilingual individuals residing in Switzerland and Peru, two regions marked by linguistic diversity. Principal Investigators: Valentina Borghesani, Marcio Soto Añari, Adolfo M. García Funds: EUR 500.000
Speech, a radar in the brain (in Spanish)
Imagine what your life would be like if you did not remember what you did yesterday, if you did not know where or with whom you were and a young man told you «we are at home and I am your son». Imagine, now, what you would feel if your body became immobile when you […]
Presenting TELL at 2024 Voice AI Symposium
Poster presentation on TELL 2.0 at 2024 Voice AI Symposium, organized by Bridge2AI-Voice Consortium. Click here for more information about the event.
TELL joins the Davos Alzheimer’s Collaborative
Our TELL team is proud to work with the Davos Alzheimer’s Collaborative to provide speech biomarkers for their groundbreaking dementia study in Kenya. This is a unique opportunity to leverage neurolinguistics and artificial intelligence for a fairer world. Learn more about DAC here.
TELL, highlighted by the Alzheimer’s Association Business Consortium
Thanks to the Alzheimer’s Association Business Consortium for the shout-out to TELL as the tool of choice for the largest speech biomarker project in Latin America, funded by the National Institutes On Aging from the National Institutes of Health. See the AABC news letter here. Learn more about the project here.
Inequities of linguistic research on brain health (in Spanish)
One of the greatest public health challenges of our era is the rise of neurodegenerative disorders. Throughout the world, diseases such as Alzheimer’s, Parkinson’s and frontotemporal dementia have high rates of disability and mortality. These conditions affect some 55 million people today, a figure that will double or triple by 2050. This growth will be […]
Of language, brain health, and global inequities
One of the greatest public health challenges of our century lies in the growth of neurodegenerative disorders. Conditions such as Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia stand as major contributors to disability and mortality in affluent and under-resourced nations alike. Currently affecting over 55 million individuals, their prevalence is expected increase significantly by 2050—especially […]